Concepedia

Laetitia Schwab

LS

4

Publications

347

Citations

4

H-Index

2016

Active since

Affiliations

Dana-Farber/Boston Children's Cancer and Blood Disorders Center(Current)

Laetitia Schwab is an author at Dana-Farber/Boston Children's Cancer and Blood Disorders Center specializing in medicine, immunology, and cellular therapies.

ORCID

Top concepts

Publications per year

2016–2022

4

Publications

4

Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access

Francesca Fumagalli, Valeria Calbi, Maria Grazia Natali Sora et al. · The Lancet · 2022 · 266 citations · Full text

Hippocampal dysfunction defines disease onset in Huntington's disease

Faye Begeti, Laetitia Schwab, Sarah Mason et al. · Journal of Neurology Neurosurgery & Psychiatry · 2016 · 59 citations

Lentiviral hematopoietic stem and progenitor cell gene therapy (HSPC-GT) for metachromatic leukodystrophy (MLD): Clinical outcomes from 33 patients

Francesca Fumagalli, Valeria Calbi, Maria Sessa et al. · Molecular Genetics and Metabolism · 2020 · 12 citations

, , +8

Lentiviral hematopoietic stem and progenitor cell gene therapy provides durable clinical benefit in early-symptomatic early-juvenile metachromatic leukodystrophy

Francesca Fumagalli, Valeria Calbi, Maria Sessa et al. · Molecular Genetics and Metabolism · 2021 · 10 citations

Rows per page

1–4 of 4